Evidence map›Paper›PMID 42075830›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Cardiovascular Risks of COVID-19 Therapeutics: Integrated Analysis of FAERS, Electronic Health Records, and Transcriptomics.

Xinran Zhu, Suguna Aishwarya Kuppa, Gibret Umeukeje, Robert Morris, Lan Bui, Kun Bu, Jie Zhang, Jin Wei, Feng Cheng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xinran ZhuDepartment of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL 33612, USA.
Suguna Aishwarya KuppaDepartment of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL 33612, USA.ORCID 0009-0007-3438-9340
Gibret UmeukejeDepartment of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL 33612, USA.ORCID 0000-0002-6708-884X
Robert MorrisDepartment of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL 33612, USA.
Lan BuiDepartment of Mathematics & Statistics, College of Art and Science, University of South Florida, Tampa, FL 33620, USA.
Kun BuDepartment of Mathematics & Statistics, College of Art and Science, University of South Florida, Tampa, FL 33620, USA.ORCID 0009-0006-9526-3023
Jie ZhangSection of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.
Jin WeiSection of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.
Feng ChengDepartment of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL 33612, USA.ORCID 0000-0003-3619-8090

Funding

The Florida Corridor Undergraduate Research Initiative 2024-2025 n.a.
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ADEbradycardiaCOVID-19 drugsEHRFAERSPaxlovidpharmacovigilanceREGEN-COVremdesivirTriNetX

Identifiers

PMID42075830
PMCPMC13118819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.